Tyler WagnerFounder, Authorsunite.com · Authorsunite.com and Partnerprofits.io Founder - #1 WSJ Bestselling Author - Book Publisher - Book Marketer - 4,000+ Authors Served - Millions Of Books Sold By Clients - Investor

Selling Off-Label Prescription Medications | The Tyler Wagner Show Shortclip - Bruce Boise

Name: Selling Off-Label Prescription Medications | The Tyler Wagner Show Shortclip - Bruce Boise
Uploaded: 2022-02-07T14:16:29+00:00
Duration: 1 min 37 s
Channel: Tyler Wagner
Description: In this short clip, former pharmaceutical sales representative Bruce Boise recounts his 24‑year career split between Carter‑Wolfe and Cephalon. He…

7 Feb 2022 · 2 min

Watch on YouTube

1:37

In this short clip, former pharmaceutical sales representative Bruce Boise recounts his 24‑year career split between Carter‑Wolfe and Cephalon. He describes how, after rising to an area manager role and earning President’s Club honors at Cephalon, the company began to market drugs for off‑label uses—a practice illegal for manufacturers but permissible for physicians. Boise explains the concept of off‑label prescribing, then focuses on Actiq, a fentanyl lollipop classified as a Schedule II opioid that is roughly 100 times more potent than morphine. He warns that promoting such a powerful drug for unapproved indications would expose patients and the company to severe legal and safety risks, and he personally refused to participate in that off‑label promotion.

Chapters

What occurred was that during my pharmaceutical career, I had one job was with Carter-Wolfe, the other job I had was Cephalon. And so I only had two companies I worked for in 24 years. The Cephalon job went great the first couple years. I was a hospital rep, then I got promoted to an area manager's job. Won President's Club with them. I was doing really well, and they started to sell off-label. And so for your audience, a doctor can prescribe off-label, and that would mean that it's outside of indication, FDA-approved indication. Yeah. And so the, the physician can write a prescription for a patient that's not doing very well in a medical condition and can be off-label to try to help that patient. A pharmaceutical company cannot promote off-label, and so that's illegal. And so the company started to promote off-label. And so when they started to promote off-label, I just wasn't going to have anything to do with that because one of the drugs that we had at the time was Actiq, and Actiq is a fentanyl. It was a— it was lollipop. It was the fentanyl lollipop. And it's a Schedule II drug, and it's 100 times more potent than morphine. And so you start to go off-label with that, and you start giving it to patients that you have no business trying to market to, you're going to get in a lot of trouble real